Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Global health burden of neurological conditions is much greater than previously understood, study reveals March 18, 2024 New research sheds light on brain inflammation in Alzheimer’s February 16, 2025 SISAQOL-IMI provides guidance for implementing patient-reported outcomes in cancer clinical trials November 26, 2025
Global health burden of neurological conditions is much greater than previously understood, study reveals March 18, 2024
SISAQOL-IMI provides guidance for implementing patient-reported outcomes in cancer clinical trials November 26, 2025